Log In
BCIQ
Print this Print this
 

nilvadipine formulation (ARC029)

  Manage Alerts
Collapse Summary General Information
Company Archer Pharmaceuticals Inc.
DescriptionSoluble amyloid reducing/clearing formulation of nilvadipine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today